The EncircleRxSM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM.
Evernorth Embarc Benefit Protection is a comprehensive program that offers patients with genetic conditions simple, affordable and predictable access to life-changing and potentially curative treatments.
Oncology in America is complex. While making advancements in prevention and treatment, many ongoing challenges exist.
As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.